Efferon raises €4.3M in seed funding to enhance its hemoadsorption technologies for critical care. The funding will support commercial expansion in Europe, India, and Latin America.
Amount Raised
€4.3 Million
Round Type
Seed
BernBiotechnologyHealth CareDescription
Efferon, a Villach, Austria-based provider of hemoadsorption devices, raised €4.3M in seed funding. Backers included existing private investors in the DACH region. The company plans to use the funds for product portfolio expansion and regulatory work. This raise brings their total funding to €6.8M.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Efferon that raised within 45 days of this round, from Fundz verified event records.
- MyoWorks raised an undisclosed amount on November 10, 2026.
- EnVision Endoscopy raised $12M (Series A) on November 10, 2026.
- Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
- Neobe raised $6.8M on November 10, 2026.
- Nanopath raised $25M (Series B) on November 10, 2026.
- Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
Who to call at Efferon, and when
A new round usually means Efferon is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Efferon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Efferon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Efferon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Efferon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Efferon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.